Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States

• Автори: John M. McLaughlin (Автор), David L. Swerdlow (Автор), Farid Khan (Автор), Oliver Will (Автор), Aaron Curry (Автор), Vincenza Snow (Автор), Raul E. Isturiz (Автор), Luis Jodar (Автор)
• Формат: Книга
• Опубліковано: Taylor & Francis Group, 2019-04-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Background: In September 2014, 13-valent pneumococcal conjugate vaccine (PCV13) was universally recommended for all US adults aged ≥65 years. Adult PCV13 coverage, including whether disparities in uptake exist, however, is not well-described. Methods: We used a monthly series of cross-sectional anal...